ReviewMayo Clinic proceedings2011

Opening a new lipid "apo-thecary": incorporating apolipoproteins as potential risk factors and treatment targets to reduce cardiovascular risk.

Terry A JacobsonPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.